Aetna Announces Appearance at 2011 Annual Credit Suisse Health Care Conference

HARTFORD, Conn.--(BUSINESS WIRE)-- Aetna (NYSE: AET) announced today that Mark T. Bertolini, chairman, CEO and president, is scheduled to make a presentation at the 2011 Annual Credit Suisse Health Care Conference on November 10, 2011, in Phoenix, Ariz.

Aetna’s presentation is scheduled to begin at 11:30 a.m. (ET). Investors, analysts and the general public are invited to listen to this presentation over the Internet via Aetna’s Investor Information link at www.aetna.com/investor. To listen to this presentation live on the Internet, visit Aetna’s web site prior to the presentation to download and install any necessary audio software. A webcast replay will be available via Aetna’s Investor Information link at www.aetna.com/investor, beginning approximately two hours after the event, for 14 days.

About Aetna

Aetna is one of the nation's leading diversified health care benefits companies, serving approximately 36.3 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com.



CONTACT:

Aetna
Media Contact:
Cynthia Michener, 860-273-8553
[email protected]
or
Investor Contact:
Tom Cowhey, 860-273-2402
[email protected]

KEYWORDS:   United States  North America  Arizona  Connecticut

INDUSTRY KEYWORDS:   Health  Professional Services  Insurance  General Health  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

As a health plan built on tech, Oscar Health was uniquely positioned to respond to the COVID-19 pandemic. 

Drugs used for ventilator patients—such as sedatives and neuromuscular blockers—are running low.

Express Scripts saved its plan sponsors $4.3 billion last year through its slate of SafeGuardRx value-based care programs.